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Alzheimer’s disease (AD) is a neurodegenerative disease characterized by 
aggregates of beta-amyloid, neurofibrillary tangles of tau protein and by the loss 
of cholinergic neurons in the basal forebrain and hippocampus. Cause of AD is 
still unknown and only symptomatic treatment is available thanks to inhibitors of 
acetylcholinesterase (AChE) and memantine, inhibitor of glutamate receptors. M1 
muscarinic positive allosteric modulators (PAM) represent another variant of 
treatment that can improve cholinergic transmission. Thanks to their selectivity, 
they are able to decrease side effects.  
The aim of the study was to measure novel compounds´ abilities to inhibit AChE 
and BChE and simultaneously act as PAM of M1 receptors. Enzymes inhibition 
was measured according to Ellman’s method and IC50 values were determined. 
For fluorescent measurement of compounds interaction with muscarinic receptor 
the CHO cell line stably expressing the M1 receptor subtype was used. Statistical 
analysis of results was performed in GraphPad Prism 5.  
None of the tested compounds acted as a PAM of M1 receptors. All novel 
compounds acted as M1 inhibitors. Moreover, AChE and BChE inhibition was 
comparable with standards. 
 
